Search hospitals

>

Illinois

>

Peoria

OSF Saint Francis Medical Center

Claim this profile

Peoria, Illinois 61603

Global Leader in Breast Cancer

Global Leader in Lung Cancer

Conducts research for Prostate Cancer

Conducts research for Breast cancer

Conducts research for Brain Tumor

457 reported clinical trials

7 medical researchers

Photo of OSF Saint Francis Medical Center in PeoriaPhoto of OSF Saint Francis Medical Center in Peoria

Summary

OSF Saint Francis Medical Center is a medical facility located in Peoria, Illinois. This center is recognized for care of Breast Cancer, Lung Cancer, Prostate Cancer, Breast cancer, Brain Tumor and other specialties. OSF Saint Francis Medical Center is involved with conducting 457 clinical trials across 566 conditions. There are 7 research doctors associated with this hospital, such as Bryan A. Faller, James L. Wade, Patrick Whitten, MD, and Priti Patel, MD.

Area of expertise

1

Breast Cancer

Global Leader

OSF Saint Francis Medical Center has run 71 trials for Breast Cancer. Some of their research focus areas include:

ER positive
HER2 negative
Stage IV
2

Lung Cancer

Global Leader

OSF Saint Francis Medical Center has run 62 trials for Lung Cancer. Some of their research focus areas include:

Stage II
Stage I
Stage III

Top PIs

Clinical Trials running at OSF Saint Francis Medical Center

Prostate Cancer

Lung Cancer

Breast Cancer

Laryngeal Cancer

Small Cell Lung Cancer

Oropharyngeal Carcinoma

Throat Cancer

Testicular cancer

Pancreatic Cancer

Stroke

Image of trial facility.

Shorter vs Usual Radiation Therapy

for Prostate Cancer

This phase III trial compares stereotactic body radiation therapy (SBRT), (five treatments over two weeks using a higher dose per treatment) to usual radiation therapy (20 to 45 treatments over 4 to 9 weeks) for the treatment of high-risk prostate cancer. SBRT uses special equipment to position a patient and deliver radiation to tumors with high precision. This method may kill tumor cells with fewer doses over a shorter period of time. This trial is evaluating if shorter duration radiation prevents cancer from coming back as well as the usual radiation treatment.

Recruiting

2 awards

Phase 3

10 criteria

Image of trial facility.

Standard Therapy + Surgery/Radiation

for Prostate Cancer

This phase III trial studies how well standard systemic therapy with or without definitive treatment (prostate removal surgery or radiation therapy) works in treating participants with prostate cancer that has spread to other places in the body. Addition of prostate removal surgery or radiation therapy to standard systemic therapy for prostate cancer may lower the chance of the cancer growing or spreading.

Recruiting

2 awards

Phase 3

30 criteria

Image of trial facility.

Apalutamide + Hormone and Radiation Therapies

for Prostate Cancer

This phase III trial studies whether adding apalutamide to the usual treatment improves outcome in patients with lymph node positive prostate cancer after surgery. Radiation therapy uses high energy x-ray to kill tumor cells and shrink tumors. Androgens, or male sex hormones, can cause the growth of prostate cancer cells. Drugs, such as apalutamide, may help stop or reduce the growth of prostate cancer cell growth by blocking the attachment of androgen to its receptors on cancer cells, a mechanism similar to stopping the entrance of a key into its lock. Adding apalutamide to the usual hormone therapy and radiation therapy after surgery may stabilize prostate cancer and prevent it from spreading and extend time without disease spreading compared to the usual approach.

Recruiting

2 awards

Phase 3

Similar Hospitals nearby

Frequently asked questions

What kind of research happens at OSF Saint Francis Medical Center?

Where is OSF Saint Francis Medical Center located?

Who should I call to ask about financial aid or insurance network?

What insurance does OSF Saint Francis Medical Center accept?

What awards or recognition has OSF Saint Francis Medical Center received?